Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb;42(2):305-311.
doi: 10.1002/clc.23145. Epub 2019 Jan 14.

Insulin resistance influences the impact of hypertension on left ventricular diastolic dysfunction in a community sample

Affiliations

Insulin resistance influences the impact of hypertension on left ventricular diastolic dysfunction in a community sample

Adamu J Bamaiyi et al. Clin Cardiol. 2019 Feb.

Abstract

Background: Although obesity-associated metabolic abnormalities (insulin resistance-IR) may not play as marked a role in determining left ventricular (LV) diastolic dysfunction (DD) as hypertension, the impact of combinations of these risk factors on DD is unknown.

Hypothesis: We hypothesized that IR influences the impact of hypertension on DD.

Methods: In 704 randomly selected participants from a community sample with a high prevalence of hypertension (50.6%) and obesity (46.5%), we determined adiposity indices, IR from the homeostasis model (HOMA-IR) and LV diastolic function using standard echocardiographic techniques.

Results: HOMA-IR was independently associated with lateral wall e' and E/e' (P < 0.05 to P < 0.005) as well as a diagnosis of DD (P < 0.02). Importantly, however, an enhanced relationship between HOMA-IR and E/e' in hypertensives (n = 356, partial r = 0.15, P < 0.005) as compared to normotensives (n = 348, partial r = 0.02 P = 0.75) was noted. Consequently, as compared to normotensives, with adjustments for confounders, hypertension was independently associated with DD only in those with the highest tertile of HOMA-IR (odds ratio = 2.65, 95% confidence interval = 1.29-5.42, P < 0.01), while in those with the lowest tertile of HOMA-IR, hypertension failed to show a higher prevalence of DD (P = 0.22).

Conclusions: Insulin resistance enhances the impact of hypertension on LV DD. Thus, DD is more likely to occur with the combination of hypertension and IR.

Keywords: hypertension; insulin resistance; left ventricular diastolic function; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflict of interests.

Figures

Figure 1
Figure 1
Multivariate adjusted indices of left ventricular diastolic function in normotensives and across tertiles of the homeostasis model of insulin resistance (HOMA‐IR) (upper panel), waist circumference (WC) (middle panel) or body mass index (BMI) (lower panel) in hypertensives of a community sample. Adjustments are for age, sex, systolic blood pressure, pulse rate, regular smoking, regular alcohol consumption, and diabetes mellitus. Tertiles of HOMA‐IR, WC, and BMI are defined Table S3. *P < 0.02, **P < 0.001, ***P < 0.0001 vs normotensives. †P < 0.05 vs hypertensives HOMA‐IR tertile 1 or vs hypertensives waist circumference tertile 1. e', myocardial tissue lengthening in early diastole at the mitral annulus; E/e', transmitral early blood flow velocity/velocity of the mean value of lateral and septal wall myocardial tissue lengthening in early diastole at the mitral annulus; LV, left ventricle
Figure 2
Figure 2
Impact of insulin resistance (homeostasis model‐homeostasis model of insulin resistance [HOMA‐IR]), waist circumference (WC) or body mass index (BMI) on the odds of independent associations between hypertension and left ventricular diastolic dysfunction. Adjustments in the left panels are for age, sex, pulse rate, regular smoking, regular alcohol consumption, and diabetes mellitus. Tertiles of HOMA‐IR, WC, and BMI are defined in Table S3

References

    1. Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011;123:2006‐2014. - PMC - PubMed
    1. Lee DS, Gona P, Vasan RS, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the National Heart, lung and blood institute. Circulation. 2009;119:3070‐3077. - PMC - PubMed
    1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251‐259. - PubMed
    1. Bhatia RS, Tu JV, Lee DS, et al. Outcomes of heart failure with preserved ejection fraction in a population‐based study. N Engl J Med. 2006;355:260‐269. - PubMed
    1. Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32:670‐679. - PMC - PubMed

MeSH terms